Fulcrum BioEnergy Secures Funding to Complete Sierra BioFuels Plant

Fulcrum BioEnergy, Inc., a leader in the next generation of advanced biofuels, announced today that it closed a $75 million Series C financing.

A portion of the financing will be used to fund the equity capital for the company's Sierra BioFuels Plant, a commercial-scale production facility designed to convert household garbage to clean, low-carbon ethanol, renewable electricity and other high value chemical products.

"With this funding, we have secured the equity capital necessary to complete our Sierra BioFuels Plant. We are excited to be starting construction on this milestone project which will demonstrate the tremendous future potential of our business," said Fulcrum's President and Chief Executive Officer E. James Macias. "Converting waste into renewable fuels and energy is about to become a reality. I'm very proud of our Fulcrum team that has consistently delivered on commercial, technical and financial milestones," added Macias.

Fulcrum has been working with Fluor on the engineering services for the project and expects to begin construction this summer. When construction is complete in late 2012, the $120 million Sierra BioFuels Plant will be one of the first commercial-scale projects operating in the U.S. with the capacity to convert post-sorted MSW into ethanol, renewable electricity and propanol. The plant will provide the Reno market with a low-cost, reliable and environmentally clean source of transportation fuel and help stimulate economic growth in Northern Nevada by creating more than 500 new, green jobs.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.